Showing 1 - 9 results of 9 for search 'Kathryn M Frietze', query time: 0.03s Refine Results
  1. 1
    Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1

    Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1 by Nikole L. Warner, Kathryn M. Frietze

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis

    Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis by Kathryn M. Frietze, Rebeccah Lijek, Bryce Chackerian

    Published 2018-11-01
    Get full text
    Article
  3. 3
    Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design

    Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design by Nikole L. Warner, Susan B. Core, Kathryn M. Frietze

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses.

    Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. by Kathryn M Frietze, Juan M Pascale, Brechla Moreno, Bryce Chackerian, David S Peabody

    Published 2017-01-01
    Get full text
    Article
  5. 5
    Epitope-Based Vaccines against the <i>Chlamydia trachomatis</i> Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice

    Epitope-Based Vaccines against the <i>Chlamydia trachomatis</i> Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice by Amanda L. Collar, Alexandria C. Linville, Susan B. Core, Kathryn M. Frietze

    Published 2022-05-01
    Get full text
    Article
  6. 6
    Ensuring equity with pre-clinical planning for chlamydia vaccines

    Ensuring equity with pre-clinical planning for chlamydia vaccines by Amanda L. Collar, Tegan N. Clarke, Andzoa N. Jamus, Kathryn M. Frietze

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum

    Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum by Nikole L. Warner, Alexandria C. Linville, Susan B. Core, Brechla Moreno, Juan M. Pascale, David S. Peabody, Bryce Chackerian, Kathryn M. Frietze

    Published 2020-09-01
    Get full text
    Article
  8. 8
    Antibodies to Variable Domain 4 Linear Epitopes of the <italic toggle="yes">Chlamydia trachomatis</italic> Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women

    Antibodies to Variable Domain 4 Linear Epitopes of the <italic toggle="yes">Chlamydia trachomatis</italic> Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution... by Amanda L. Collar, Alexandria C. Linville, Susan B. Core, Cosette M. Wheeler, William M. Geisler, David S. Peabody, Bryce Chackerian, Kathryn M. Frietze

    Published 2020-10-01
    Get full text
    Article
  9. 9
    Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against <i>Chlamydia trachomatis</i> Type 3 Secretion System Tip Protein, CT584

    Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against <i>Chlamydia trachomatis</i> Type 3 Secretion System Tip Protein, CT584 by Everett Webster, Kyra W. Seiger, Susan B. Core, Amanda L. Collar, Hannah Knapp-Broas, June Graham, Muskan Shrestha, Sarah Afzaal, William M. Geisler, Cosette M. Wheeler, Bryce Chackerian, Kathryn M. Frietze, Rebeccah S. Lijek

    Published 2022-01-01
    Get full text
    Article

Search Tools: